Smoking and hepatocellular carcinoma mortality

Experimental and Therapeutic Medicine

Volumn 3, Issue 1, 2012, Pages 124-128

  Siegel, Abby B ^a   Conner, Kristina ^a   Wang, Shuang ^b   Jacobson, Judith S ^b   Hershman, Dawn L ^a   Hidalgo, Rosa ^a   Verna, Elizabeth C ^a   Halazun, Karim ^a   Brubaker, William ^a   Zaretsky, Jonah ^a   Moniodis, Anna ^a   Delgado Cruzata, Lissette ^b   Dove, Lorna ^a   Emond, Jean ^a   Kato, Tomoaki ^a   Brown, Robert S ^a   Neugut, Alfred I ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE   (United States)

Author keywords

Hepatocellular carcinoma; Mortality; Smoking

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; ASIAN; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CIGARETTE SMOKING; DEMOGRAPHY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HAZARD RATIO; HISPANIC; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGNOSIS; PROTEIN ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION;

EID: 84855400127     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.351     Document Type: Article

References (12)

1. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr and Doll R: Mortality from smoking worldwide. Br Med Bull 52: 12-21, 1996.
2. Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C and Calle EE: Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst 92: 1888-1896, 2000.
3. Ogimoto I, Shibata A, Kurozawa Y, et al: Risk of death due to hepatocellular carcinoma among smokers and ex-smokers. Univariate analysis of JACC study data. Kurume Med J 51: 71-81, 2004.
4. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL and Lok AS: Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42: 218-224, 2005.
5. Batty GD, Kivimaki M, Gray L, Smith GD, Marmot MG and Shipley MJ: Cigarette smoking and site-specific cancer mortality: testing uncertain associations using extended follow-up of the original Whitehall study. Ann Oncol 19: 996-1002, 2008.
6. Taioli E: Gene-environment interaction in tobacco-related cancers. Carcinogenesis 29: 1467-1474, 2008.
7. Yu MC and Yuan JM: Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127: S72-S78, 2004.
8. Evans AA, Chen G, Ross EA, Shen FM, Lin WY and London WT: Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 11: 369-376, 2002.
9. Wong LL, Limm WM, Tsai N and Severino R: Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients. World J Gastroenterol 11: 3491-3497, 2005.
10. Ockene JK, Kuller LH, Svendsen KH and Meilahn E: The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health 80: 954-958, 1990.
11. Bruix J and Sherman M: Management of hepatocellular carcinoma. Hepatology 42: 1208-1236, 2005.
12. Yu JC, Neugut AI, Wang S, et al: Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma. Cancer 116: 1801-1809, 2010.